Universität Wien

Master Drug Discovery and Development (606)

MPS1 Einführung in Drug Discovery und Preclinical Drug Development (8 ECTS)
MPS2 Grundlagen der Arzneistoffentwicklung (8 ECTS)
MPS3 Drug Discovery (7 ECTS)
MPS4 Preclinical Drug Development (7 ECTS)
MPS5 Advanced Methods in Drug Discovery and Preclinical Drug Development (15 ECTS)
320008 VO 0.5 ECTS [en] Protein Stability and Formulation
Müller
323101 VU 2 ECTS [en] Pharmacoinformatics - MPS5
Ecker
323102 VU 4 ECTS [en] Pharmacoinformatics Practical Course - MPS5
Ecker
323103 VU 2 ECTS [en] Data science approaches for advancing drug discovery - MPS5
Zdrazil
323104 VU 2 ECTS [en] Biophysical Methods in Drug Discovery and Development - MPS5
Ecker
323105 VU 2 ECTS [en] Innovation & Leadership in Preclinical Drug Development - MPS5
Bryant
323106 VU 2 ECTS [en] Safety testing and risk assessment in drug development - MPS5
Dornetshuber-Fleiss
323107 VU 4 ECTS [en] Advanced Organic Synthesis - MPS5
Pace
323108 VU 2 ECTS [en] Cardiac toxicity studies on ion channels - MPS5 - from automated patch clamp on cell lines to stem cell derived human cardiomyocytes
Hering
323109 VU 2 ECTS [en] Drug targets, hit discovery and case studies - MPS5
Mikros
323110 VU 2 ECTS [en] Assays and Methods in Drug Discovery - MPS5
Atanasov
323111 VU 2 ECTS [en] Hit and Lead Finding Approaches and Use Cases - MPS5
Ettmayer, Do 14:30-16:00 (5×)
MPS6 Experimental Methods in Drug Discovery und Preclinical Drug Development (10 ECTS)
323007 UE 10 ECTS [en] Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6
Rollinger
MPS7 Case Studies in Drug Discovery und Preclinical Drug Development (5 ECTS)
323008 SE 5 ECTS [en] Case Studies in Drug Discovery and Preclinical Drug Development - MPS7 - (2 Courses)
Ecker
MPS8 Forschungspraktikum (20 ECTS)
MPS9 Verfassen eines Forschungsantrages (5 ECTS)
MPS10 Zusatzqualifikation und wissenschaftliche Vertiefung (5 ECTS)

Letzte Änderung: Fr 29.06.2018 00:29